Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease
Laith N AL-Eitan,1,2 Ayah Y Almasri,1 Sahar O Al-Habahbeh1 1Department of Applied Biological Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan; 2Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid 22110, Jordan Purpose: The...
Main Authors: | AL-Eitan LN, Almasri AY, Al-Habahbeh SO |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-a-variable-number-tandem-repeat-in-the-cyp2c9-promoter-on-wa-peer-reviewed-article-PGPM |
Similar Items
-
Frequency of <i>CYP2C9</i> Promoter Variable Number Tandem Repeat Polymorphism in a Spanish Population: Linkage Disequilibrium with <i>CYP2C9*3</i> Allele
by: Pedro Dorado, et al.
Published: (2022-05-01) -
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01) -
Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
by: AL-Eitan LN, et al.
Published: (2019-01-01) -
Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity
by: Ibdah RK, et al.
Published: (2021-01-01) -
Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population
by: Dongxu Wang, et al.
Published: (2022-11-01)